Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 14. June 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3452  Previews Next
   
   Articles 1 - 20 / 69031  
   
Impact of community mental health center follow-up on psychiatric hospitalization burden in schizophrenia spectrum disorders: a retrospective mirror-image study.
BMC Psychiatry
Usta H, Yilmazer .
PMID: 42286553 [PubMed - as supplied by publisher]


Optimizing tDCS cognitive outcomes in schizophrenia: the role of dopaminergic tone and antipsychotic load.
Transl Psychiatry
García-Fernández L, Romero-Ferreiro V, Muñoz-Gualan AP, Cardona-Bejarano S, de Los Santos D, Ripoll Ayús I, Moleón-Ruiz Á, Martín-Bejarano García M, Wynn R, Rodriguez-Jimenez R.
PMID: 42285955 [PubMed - as supplied by publisher]


DREAMSPHEN: a randomised controlled study comparing dose reduction of antipsychotics vs maintenance treatment in schizophrenia spectrum disorder after stratification based on patients' psychotic phenotype - study protocol of a personalised medicine approach.
BMJ Open
Berna F, Horowitz MA, Javelot H, Meyer N, Foucher JR.
PMID: 42285570 [PubMed - indexed for MEDLINE]


The effectiveness and tolerability of trauma-focused interventions for trauma symptoms in individuals who have psychosis: A systematic review and meta-analysis.
Schizophr Res
Mason A, Logeswaran Y, Opper F, Khan H, Johns L.
PMID: 42284952 [PubMed - as supplied by publisher]


Social deprivation in schizophrenia spectrum disorders: A systematic review.
J Psychiatr Res
Monari S, Saccaro LF, Kirschner M, Kaiser S, Bolano S, Sabé M.
PMID: 42284805 [PubMed - as supplied by publisher]


Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History.
J Clin Psychiatry
Steinle JT, Shankar S, Siegel JS, Cabassa LJ, Adams DR, Cavazos-Rehg P, Agrawal A, Nicol GE, Grucza R, Xu KY.
PMID: 42283542 [PubMed - in process]


Caregiver Burden of Outpatients with Schizophrenia: A Post-Hoc Study Comparing Patients on Clozapine Versus Patients on Other Antipsychotics.
Int J Soc Psychiatry
Di Sarno E, Kayo M, Louzã MR.
PMID: 42283408 [PubMed - as supplied by publisher]


Identifying circulating protein targets for common factors underlying schizophrenia, depression, and bipolar disorder.
medRxiv
Duan J, Su CY, Yoshiji S, Zhang W, Lu T.
PMID: 42282184 [PubMed]


Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder.
Psychiatr Res Clin Pract
Smagula SF, Gannon JM, Ferrarelli F.
PMID: 42281902 [PubMed]


Multimodal EEG-MRI Neuroimaging in Schizophrenia-A Systematic and Mechanistic Review.
J Clin Med
Chmiel J, Kopa.
PMID: 42279166 [PubMed]


Substance Use and Incidence of Psychosis Diagnoses Among Gay, Bisexual, and Other Men Who Have Sex with Men Compared with Males from the General Population: A Matched Cohort Study from Metro Vancouver, Canada.
Subst Use Misuse
Gormezano A, Adams A, Wang L, Trigg J, Budu M, Hogg RS, Aguilera-Mijares S, Hull M, Barath J, Sereda P, Lal A, Cox J, Hart TA, Grace D, Tan DHS, Lachowsky NJ, Moore DM.
PMID: 42276816 [PubMed - as supplied by publisher]


Meta-analysis of brain and blood transcriptional signatures of neuroimmune dysregulation in Schizophrenia: convergent evidence for excessive complement system activity and CX3CL1-CX3CR1 axis disruption.
Brain Behav Immun
Boughanmi ME, Lespine LF, Leboyer M, Demily C, Rey R.
PMID: 42276261 [PubMed - as supplied by publisher]


Beyond categorical boundaries: Common molecular and cellular pathways in autism spectrum disorder and schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry
Alruwaili NS, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Bogari NM, Alhelfawi S, Alruwaili M, Batiha GE.
PMID: 42276200 [PubMed - as supplied by publisher]


Psychopathology, cognitive and social function, and ERP indices at the lower state of psychosis continuum: a case control study.
J Psychiatr Res
Sun M, Sun MZ, Mi L, Zhang JW, Li R, Li Y, Zhou HL, Yang WJ, Wang DF, Zheng YJ, Zhou L.
PMID: 42275749 [PubMed - as supplied by publisher]


Cognitive remediation therapy in low-and-middle-income countries (LAMICs) for people with psychosis: a systematic review of its efficacy on functional and cognitive outcomes.
Soc Psychiatry Psychiatr Epidemiol
Vig Y, Gebreegziabher Y, Hanlon C, Cella M.
PMID: 42274736 [PubMed - as supplied by publisher]


Gamma auditory steady-state response and remission in antipsychotic-naïve patients at clinical high risk for psychosis: a longitudinal study.
World J Biol Psychiatry
Kiang M, Lepock JR, Mizrahi R, Gerritsen CJ, Korostil M, Light GA.
PMID: 42274463 [PubMed - as supplied by publisher]


The relationship between social media use, quality of life, and clinical symptoms in schizophrenia: a cross-sectional study.
BMC Psychol
Kirkan TS, Tunc EB, Demiray G.
PMID: 42271523 [PubMed - as supplied by publisher]


Association between serum non-enzymatic antioxidants and cognitive impairment in drug-naïve patients with schizophrenia.
BMC Psychiatry
Feng Z, Qiu Y, Wang Y, Li M, Sun X, Su Q, Xuekelaiti Z, Wang S, Xu Y, Zhang Y, Li J.
PMID: 42271292 [PubMed - as supplied by publisher]


Predicting transition to psychiatric disorders in clinical high-risk for psychosis subjects using machine learning and facial features.
Schizophr Res
Loch AA, Queluz FH, Waurzenczak B, Gondim JM, Argolo FC, Lopes-Rocha AC, van de Bilt MT, de Jesus LP, Jafet AF, Gattaz WF, Cecchi GA, Corcoran CM, Ara A.
PMID: 42269195 [PubMed - as supplied by publisher]


Computerized assessments of emotional expression and emotional reactivity predict negative symptoms in individuals at clinical high-risk for psychosis.
Psychol Med
Bertrand CE, Pokorny VJ, Gold JM, Waltz JA, Schiffman J, Ellman LM, Strauss GP, Walker EF, Woods SW, Powers AR, Kenney J, Corlett PR, Silverstein SM, Mittal VA.
PMID: 42267441 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 69031    Page 1 of 3452  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1